TOTAL VOLUME:

$134b

24H VOL:

$107,351,958

24H TRANSACTIONS:

2,388,728,490

OPEN INTEREST:

$1,416,970,024

400,720

Markets across

30,097

events

MATCHED EVENTS:

2,633

PLATFORM COVERAGE:

5

Polymarket:

39%

VS.

Kalshi:

61%

BETA
Dashboards
Insights
Indices
Tour
All
Trending
Breaking
New
Ending Soon
Politics
Sports
Crypto
Companies
Elections
Financials
Economics
Other
Entertainment
Science and Technology
When will the FDA approve Orforglipron?
kalshi

When will the FDA approve Orforglipron?

Volume:
$23,650

Before April 4

 - Kalshi

Before April 4 - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Apr 1, 2026

Closed: Apr 11, 10:00 AM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Before April 4

View
100%
Yes 100¢No 0¢
—
N/A
$6,490
N/A
N/A
$3,040
Settled
Yes
kalshi

Before April 10

View
100%
Yes 100¢No 0¢
—
N/A
$5,067
N/A
N/A
$4,385
Settled
Yes
kalshi

Before April 8

View
100%
Yes 100¢No 0¢
—
N/A
$5,054
N/A
N/A
$3,116
Settled
Yes
kalshi

Before April 6

View
100%
Yes 100¢No 0¢
—
N/A
$3,689
N/A
N/A
$3,013
Settled
Yes
kalshi

Before April 11

View
100%
Yes 100¢No 0¢
—
N/A
$3,350
N/A
N/A
$2,849
Settled
Yes
Total markets: 5

Description

The FDA's review and potential approval of Orforglipron, a pharmaceutical drug, for marketing authorization in the United States during early April 2026.